ALKERMES INSPIRATION GRANTS™ Program

Application Information

(Please read carefully) On ly el igible* 501(c)(3) non-profi t organ izations may apply. These include, but are not l imited to, patient organ izations and professional societies.

Grant Awards Emergence Grant | up to $25 ,000

Innovation Grant | up to $100,000

Alkermes is pleased to announce a new competitive grant program. ALKERMES INSPIRATION GRANTS were developed to underscore our ongoing commitment to support the comprehensive needs of people affected by mental health and substance use disorders. Through this initiative, Alkermes will award up to $1 million in grants for the development or expansion of innovative programs to support the mental health and addiction communities in two key areas:

! Improving or enhancing systems of care

! Integrating the perspective of people affected by mental illness or addiction into drug development or care delivery

The submission period will be open from September 12 to October 7 and grants will be awarded to selected organizations in November 2016. El igible* non-profit organizations may apply for grants of up to $25,000 (Emergence Grant) or up to $100,000 (Innovation Grant). Multiple submissions are permitted. Winning programs will be selected by Alkermes in partnership with a group of external reviewers who represent the perspectives of the community. These reviewers include a patient advocate, a representative from the criminal justice system, a person in recovery and a caregiver. Proposals will be evaluated based on a standard set of review criteria, which will include the quality of the application, creativity of the solution and the organization’s infrastructure and past program success. Funding will be distributed at the end of 2016. For more information on the ALKERMES INSPIRATION GRANTS program or to apply, please visit http://www.alkermes.com/inspirationgrants or email inspirationgrants@alkermes.com.

Grant Categories

The l i st below provides suggested program areas el igible for funding. Please note these are suggested areas on ly and may not in include al l possible program concepts. We encourage you to be creative and innovative in your organ ization ’s efforts to best meet the needs of the community.

Evaluation Criteria Proposals wi l l be reviewed by A lkermes, in partnersh ip with an external review committee, in October 2016. Cri teria for review wi l l include the fol lowing: ! Completed proposal

! Clearly defined need and objectives

! Supporting research

! Creativity

! Potential impact

! Budget

! Ability to implement

! Sustainable and/or replicable

! Evaluation/metrics

Improving or enhancing systems of care ! Early intervention

! Stigma reduction

! Psychosocial support or evaluation of existing services (e.g., peer-based support, adjunctive behavioral treatment modal i ties, etc.)

! Caregiver support or evaluation of existing services

! Programs that l ink community services

! Transi tional support, housing, employment or other wrap-around services

! Relapse prevention and recovery

! Innovative criminal justice programs

Integrating the perspective of people affected by mental health or addiction into drug development or care delivery ! Cl in ical trial education , operational

enhancements and support services

! Development of new tools or resources to understand patient preferences

! Decision aid resources to support improved cl in ician/patient dialogue

! Train ing programs to enable patients or advocates to understand the drug development process and play a more active role

Eligibility* Exclusion Criteria We wi l l not consider proposals that include any of the fol lowing exclusion cri teria: ! Programs that reference A lkermes products or product candidates, or seek to

measure the impacts of A lkermes products (programs that measure outcomes general ly that are not tied to speci f ic treatments may be considered)

! Individuals or a heal thcare professional ’s private practice, including enti ties associated with , or control led by an individual heal thcare professional or heal thcare professional ’s private practice

! Organizations that discriminate on the basis of age, race, sex, rel igion , sexual orientation or disabi l i ty

! Funding for events or programs that have al ready occurred

! Pol i tical organ izations, campaigns or di rect lobbying activi ties

! Rel igious organ izations or groups whose activi ties are primari ly sectarian in purpose

! Programs or proposals that supplement an organ ization ’s income or offset i ts expenses in a manner that benefi ts, di rectly or indi rectly, a heal thcare provider’s compensation

Alkermes is committed to complying with all applicable regulations and codes pertaining to education grants. Alkermes follows the requirements of the Compliance Program Guidance for Pharmaceutical Manufacturers issued by the Department of Health and Human Services Office of the Inspector General (“OIG Guidelines”), the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (“PhRMA Code”), the FDA Guidance to Industry Supported Scientific and Educational Activities, and the Accreditation Council for Continuing Medical Education (“ACCME”) Standards for Commercial Support. Alkermes does not provide support for programs that are intended to encourage, induce, or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer, or arrange for the purchase, sale or recommendation, or formulary placement of any Alkermes’ product.